Envestnet Asset Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Envestnet Asset Management's BTAL Position: Q2 2026 in Review
Envestnet Asset Management reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 92% in Q2 2026, selling an estimated $2.07M and leaving 14,210 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #4686.
Envestnet Asset Management first reported a position in BTAL in Q2 2020 and has held it in 19 quarters since. The position peaked at $6.3M in Q4 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Envestnet Asset Management held 14,210 shares of AGF US Market Neutral Anti-Beta Fund worth $158K as of Q2 2026.
- Envestnet Asset Management sold 170,560 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $2.07M.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4686 holding.
- Envestnet Asset Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2020 and has held it in 19 quarters since.
- Envestnet Asset Management's AGF US Market Neutral Anti-Beta Fund position peaked at $6.3M in Q4 2023.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.